TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.

Fiche du document

Auteurs
Date

8 juin 2020

Types de document
Périmètre
Langue
Identifiants
Source

Serveur académique Lausannois

Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ccell.2020.05.008

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32425702

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1878-3686

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_F9BFA1700A3B4

Collection

Serveur Académique Lausannois

Organisation

Université de Lausanne et CHUV

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer

Mots-clés 0

Betacoronavirus/isolation & purification; Betacoronavirus/pathogenicity; Coronavirus Infections/complications; Coronavirus Infections/epidemiology; Coronavirus Infections/therapy; Coronavirus Infections/virology; Global Burden of Disease; Humans; International Cooperation; Intersectoral Collaboration; Medical Oncology/organization & administration; Medical Oncology/standards; Pandemics; Pneumonia, Viral/complications; Pneumonia, Viral/epidemiology; Pneumonia, Viral/therapy; Pneumonia, Viral/virology; Practice Guidelines as Topic; Registries; Thoracic Neoplasms/complications; Thoracic Neoplasms/mortality; Thoracic Neoplasms/therapy

Sujets proches En

Pneumonitis Lungs--Inflammation

Citer ce document

J.G. Whisenant et al., « TERAVOLT: Thoracic Cancers International COVID-19 Collaboration. », Serveur académique Lausannois, ID : 10.1016/j.ccell.2020.05.008

Métriques

Partage / Export

Résumé 0

Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en